SCHEMBL21766931

SCHEMBL21766931

COc1cccc(-c2nnc(NSCC(O)c3ccc(F)cn3)n2-c2c(OC)cccc2OC)n1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
APLNR P35414 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21767040 0.89 APLNR (0.70) APLNR
SCHEMBL21767161 0.86 APLNR (0.71) APLNR
SCHEMBL18247128 0.83 APLNR (1.00) APLNR
SCHEMBL18246034 0.83 APLNR (1.00) APLNR
SCHEMBL28454613 0.83 APLNR (1.00) APLNR
SCHEMBL20200780 0.83 APLNR (0.71) APLNR
SCHEMBL21767090 0.82 APLNR (0.56) APLNR
SCHEMBL21766935 0.79 APLNR (0.71) APLNR
SCHEMBL20207474 0.78 APLNR (0.73) APLNR
SCHEMBL21767143 0.78 APLNR (0.70) APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3300500-B1 TRIAZOLE AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2020-02-26 EP disclosed